These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 7518975

  • 41. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
    Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Richards TM, Crotty PH, Beaver SJ, Steers JL, Wiesner RH.
    Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
    [Abstract] [Full Text] [Related]

  • 42. Risk factors for the development of chronic cyclosporine-nephrotoxicity.
    Mihatsch MJ, Steiner K, Abeywickrama KH, Landmann J, Thiel G.
    Clin Nephrol; 1988 Apr; 29(4):165-75. PubMed ID: 3284669
    [Abstract] [Full Text] [Related]

  • 43. [Prophylaxis and management of early acute renal failure after orthotopic liver transplantation].
    Ma Y, Tai Q, He XS, Wang GD, Zhu XF.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 27; 89(39):2764-7. PubMed ID: 20137599
    [Abstract] [Full Text] [Related]

  • 44. The nephrotoxicity of FK506 as compared with cyclosporine.
    McCauley J.
    Curr Opin Nephrol Hypertens; 1993 Jul 27; 2(4):662-9. PubMed ID: 7532089
    [Abstract] [Full Text] [Related]

  • 45. Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation.
    Ellis D, Avner ED.
    Clin Nephrol; 1986 Jun 27; 25(6):295-303. PubMed ID: 3524924
    [Abstract] [Full Text] [Related]

  • 46. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
    McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW.
    J Pediatr Gastroenterol Nutr; 1995 Apr 27; 20(3):291-9. PubMed ID: 7541834
    [Abstract] [Full Text] [Related]

  • 47. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
    Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, Gores G, Hay E, Dickson ER, Krom RA.
    Transplantation; 1993 Jun 27; 55(6):1332-9. PubMed ID: 7685934
    [Abstract] [Full Text] [Related]

  • 48. [Acute renal failure caused by ceporin, kanamycin and gentamicin].
    Sierra RR, Torres AM, Rodriguez RB, Albelo IM.
    Urol Nefrol (Mosk); 1989 Jun 27; (2):50-3. PubMed ID: 2728142
    [Abstract] [Full Text] [Related]

  • 49. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.
    de Mattos AM, Olyaei AJ, Bennett WM.
    Am J Kidney Dis; 2000 Feb 27; 35(2):333-46. PubMed ID: 10676738
    [Abstract] [Full Text] [Related]

  • 50. Changing patterns and outcome of acute renal failure requiring hemodialysis.
    Abreo K, Moorthy AV, Osborne M.
    Arch Intern Med; 1986 Jul 27; 146(7):1338-41. PubMed ID: 3718131
    [Abstract] [Full Text] [Related]

  • 51. Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression.
    Pham H, Lemoine A, Salvucci M, Azoulay D, Frenoy N, Samuel D, Reynès M, Bismuth H, Debuire B.
    Liver Transpl Surg; 1998 Mar 27; 4(2):146-51. PubMed ID: 9516567
    [Abstract] [Full Text] [Related]

  • 52. Incidence and clinical profile of microvascular complications in renal allografted patients treated with cyclosporine.
    Noël C, Saunier P, Hazzan M, Pruvot FR, Dracon M, Jude B, Lelièvre G.
    Ann Med Interne (Paris); 1992 Mar 27; 143 Suppl 1():33-6. PubMed ID: 1300884
    [Abstract] [Full Text] [Related]

  • 53. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.
    Sakr M, Hassanein T, Gavaler J, Abu-Elmagd K, Fung J, Gordon R, Starzl T, Van Thiel D.
    Transplantation; 1992 Apr 27; 53(4):786-91. PubMed ID: 1373535
    [Abstract] [Full Text] [Related]

  • 54. [Acute renal failure in patients with hematologic neoplasms].
    Okada S, Miyoshi Y, Takizawa Y, Hagiwara S, Mori H, Niikura H, Terada H.
    Rinsho Ketsueki; 1990 Apr 27; 31(4):431-7. PubMed ID: 2381056
    [Abstract] [Full Text] [Related]

  • 55. Impact of RIFLE classification in liver transplantation.
    Ferreira AC, Nolasco F, Carvalho D, Sampaio S, Baptista A, Pessegueiro P, Monteiro E, Mourão L, Barroso E.
    Clin Transplant; 2010 Apr 27; 24(3):394-400. PubMed ID: 19744093
    [Abstract] [Full Text] [Related]

  • 56. Acute renal failure induced by foscarnet: 4 cases.
    Cacoub P, Deray G, Baumelou A, Le Hoang P, Rozenbaum W, Gentilini M, Soubrie C, Rousselie R, Jacobs C.
    Clin Nephrol; 1988 Jun 27; 29(6):315-8. PubMed ID: 2840226
    [Abstract] [Full Text] [Related]

  • 57. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
    Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE.
    Transplantation; 1992 May 27; 53(5):1056-62. PubMed ID: 1374944
    [Abstract] [Full Text] [Related]

  • 58. [Acute renal failure in abdominal infection. Comparison of hemodialysis and continuous arteriovenous hemofiltration].
    Mauritz W, Sporn P, Schindler I, Zadrobilek E, Roth E, Appel W.
    Anasth Intensivther Notfallmed; 1986 Aug 27; 21(4):212-7. PubMed ID: 3752430
    [Abstract] [Full Text] [Related]

  • 59. Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506.
    Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM.
    Transplantation; 1994 Apr 15; 57(7):1132-3. PubMed ID: 7513099
    [No Abstract] [Full Text] [Related]

  • 60. Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.
    Ericzon BG, Eusufzai S, Söderdahl G, Duraj F, Einarsson K, Angelin B.
    Transplantation; 1997 Jan 15; 63(1):74-80. PubMed ID: 9000664
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.